BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments

Brainstorm Cell Therapeutics Inc., a leading developer of adult stem cell therapeutics for neurodegenerative diseases, provided an update on the grant and allowance of three patent applications for NurOwn® and NurOwn-Exosomes.